Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and ...

Novo Nordisk A/S surged on expectations that some competition for its blockbuster obesity shot Wegovy will subside, paving ...

He’s a 30-year-old systems engineer who isn’t taking no for an answer when it comes to access to this life-changing weight ...

In a state like Kansas — where miles often separate families from the nearest specialty medical center — access to affordable ...

This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--is now no longer listed as being in short supply in the U.S. and the FDA has told anyone distributing copies of the ...

A coalition of 20 attorneys general are suing to block what they say is the Trump administration's “dangerous dismantling” of the federal health agency, adding that recent actions endanger programs, ...

The FDA has released its report on the 2023 actions of its Core Outbreak Response and Evaluation network. The network’s ...

The FDA is stepping up its unannounced inspections of foreign manufacturing facilities. In a statement about the increase in inspections, the Food and ...

There are 164,000 people in Virginia age 65 and older who suffer from Alzheimer’s, but two new drugs approved by the Food and Drug Administration could offer hope to those in the early ...